According to our study, we now know that the overall anti-melanoma efficacy of ZD55-IL-24 in patients should be contributed by the direct killing pathway, antitumor immunity pathway, IL-24-mediated other antitumor pathway, and anti-angiogenesis pathway (Supplementary Fig. 10). The gene discussed is IL24; the disease is melanoma.